XRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
XORTX Therapeutics Inc.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026
$1.01−0.23 (-18.55%)
Close on Oct 19, 2026
Community
Notes and questions about XORTX Therapeutics from other investors
No posts about XRTX yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.